Dendritic cell-based cancer immunotherapies. - Wikidata - wikimedia - TriplyDB

Dendritic cell-based cancer immunotherapies.

Dendritic cell-based cancer immunotherapies.

http://www.wikidata.org/entity/Q37500014

about

Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies The application of exosomes as a nanoscale cancer vaccine.CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cells.Comparison of cytotoxic T lymphocyte responses against pancreatic cancer induced by dendritic cells transfected with total tumor RNA and fusion hybrided with tumor cell.Dendritic cell-based vaccines for the therapy of experimental tumors.Human dendritic cells transfected with amplified MUC1 mRNA stimulate cytotoxic T lymphocyte responses against pancreatic cancer in vitro.Increased frequency of circulating invariant natural killer T cells in malignant pleural mesothelioma patients.

P2860

Q33361158-CDE51DD5-B2C2-4592-B45A-4C72DA94B6AF Q34343272-13C851CF-CB5E-4007-A37B-FF2B2EB891A4 Q34409830-63D15E72-7C8A-43A8-9E04-4F21B4FAACCB Q37071139-F0167B07-A109-4C4C-A955-A1BE8ACA10E8 Q37773259-9A604BA7-56EB-4ACC-9D93-49AE24A566DA Q39467521-8799953C-A1A2-470B-85F7-0132B7912A88 Q46190547-49758AE4-4329-46C1-BC62-74EF137B8A71

P2860

Dendritic cell-based cancer immunotherapies.

http://www.wikidata.org/entity/Q37500014

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dendritic cell-based cancer immunotherapies.

@en

Dendritic cell-based cancer immunotherapies.

@nl

type

label

Dendritic cell-based cancer immunotherapies.

@en

Dendritic cell-based cancer immunotherapies.

@nl

prefLabel

Dendritic cell-based cancer immunotherapies.

@en

Dendritic cell-based cancer immunotherapies.

@nl

P1433

Q37500014-1B763418-BC24-43AB-8BC3-3FB8087A4848

P1476

Q37500014-B11A2059-EF5E-43EC-BB29-8C5718D68741

P2093

Q37500014-10156060-0C77-4665-BA40-34C3F9F4DCE8

Q37500014-2AA20CC2-1139-4A49-B820-E4C66302728F

Q37500014-540B273E-8A06-4947-BD34-889B2855A723

Q37500014-59743439-FA54-433B-BDDC-BAC48E4B3857

Q37500014-AFED4683-0688-442D-8775-B67B2F1836E0

Q37500014-E2A6DD02-08F7-4461-A87C-55D2D6EAC62C

P2860

Q37500014-088B8419-090E-47EA-9D99-5620E886CBE1

Q37500014-277DF366-CCB4-4BF2-A888-806BB791604F

Q37500014-2B13AE2D-02B0-4081-B6E8-0D835C7AFCC0

Q37500014-332B9FB3-516F-4A17-9C57-49F0BABEF208

Q37500014-64914010-B880-41D4-8587-121DDC3017FE

Q37500014-862E4C0D-E44C-48FB-8773-BAF7F54FC45A

Q37500014-BF86CCA7-7F0F-46E5-B80E-0B18AFB84204

Q37500014-C0EC83F7-37CA-47B2-9649-016F12342E7F

Q37500014-C143F09B-4A2E-42AF-92DB-4E3C5D479B35

Q37500014-CDA154A9-2B4E-47B7-B13E-C44663EF2E35

P2888

Q37500014-F42EC78A-FB94-4C85-9A0C-746B09F18CE5

P304

Q37500014-53F87E69-5719-481C-AB00-C984BA133CF6

P31

Q37500014-3922E0F8-8AB2-4B74-91F7-337AEF2AF6D4

P356

Q37500014-97A95441-3000-4D67-8D75-DF10E744FB54

P433

Q37500014-6DE56581-CF18-42A2-8FB8-0F6799846F4A

P478

Q37500014-86DE62C8-7050-4594-A4CE-C3E8C99DCB12

P577

Q37500014-F9A02E31-B9AB-449A-8CE6-A65233E3C4FD

P698

Q37500014-9820BDFC-5AA2-4F47-B860-0BF57640022D

P921

Q37500014-8D0ADE66-21CE-42F0-B6E2-CFFC9CC52AFF

P356

S00005-009-0025-X

P1433

Archivum Immunologiae et Therapiae Experimentalis

P1476

Dendritic cell-based cancer immunotherapies.

@en

P2093

Kanako Shimizu

http://www.w3.org/2001/XMLSchema#string

Kaori Aki

http://www.w3.org/2001/XMLSchema#string

Koji Fujimoto

http://www.w3.org/2001/XMLSchema#string

Miki Asakura

http://www.w3.org/2001/XMLSchema#string

Shin-ichiro Fujii

http://www.w3.org/2001/XMLSchema#string

Takuya Takayama

http://www.w3.org/2001/XMLSchema#string

P2860

Diversity and recognition efficiency of T cell responses to cancer

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant.

NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis.

Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice.

Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70.

TNF skews monocyte differentiation from macrophages to dendritic cells.

Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines.

Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.

Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells.

P2888

s00005-009-0025-x

P304

189-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00005-009-0025-X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19479202

http://www.w3.org/2001/XMLSchema#string

P921